Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells: Role of cGMP and cGMP-dependent protein kinase

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 414-421

  Kumar, Ravindra ^a   Cartledge, Willie A ^a   Lincoln, Thomas M ^b   Pandey, Kailash N ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

angiotensin II; atrial natriuretic peptide; cGMP; cyclase receptor A; guanylyl; phorbol ester; protein kinase C; vascular smooth muscle cells

Indexed keywords

8 BROMO CYCLIC GMP; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; COMPLEMENTARY DNA; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIN 1; GUANYLATE CYCLASE; KT 5823; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; ENZYME ACTIVITY; FLUID BALANCE; HYPERTENSION; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; STEROIDOGENESIS;

EID: 0031037230     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.414     Document Type: Article

References (60)

1. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science. 1985;230:767-770.
2. Inagami T. Atrial natriuretic factor. J Biol Chem. 1989;264: 3043-3046.
3. Brenner BM, Ballerman BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 1990;70: 665-699.
4. Levin ER. Natriuretic peptide C-receptor: more than a clearance receptor. Am J Physiol. 1993;264:E483-E489.
5. Garbers DL. Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell. 1992;71:1-4.
6. Garbers DL. Guanylate cyclase, a cell surface receptor. J Biol Chem. 1989;264:9103-9106.
7. Pandey KN, Singh S. Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem. 1990;265:12342-12348.
8. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991;252: 120-123.
9. Suga S-I, Nakao K, Hosada K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inoue K, Imura H. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide and C-type natriuretic peptide. Endocrinology. 1992;130:229-239.
10. Maack T, Suzuki M, Alemida FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA. Physiological role of silent receptors of atrial natriuretic factor. Science. 1987;238:675-678.
11. Pandey KN, Pavlou SN, Inagami T. Identification and characterization of three distinct atrial natriuretic factor receptors: evidence for tissue specific heterogeneity of receptor subtypes in vascular smooth muscle, kidney tubular epithelium and Leydig tumor cells. J Biol Chem. 1988;263:13406-13413.
12. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol. 1992;54:11-27.
13. Stingo AJ, Clavell AL, Aarhus LL, Burnett JC Jr. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 1992; 262:H308-H312.
14. Clavell AL, Stingo AJ, Wei C-M, Heublein DM, Burnett JC Jr. C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol. 1993;264:R290-R295.
15. Pandey KN. Vascular action and interaction of natriuretic peptide receptors. In: Sowers JR, ed. Contemporary Endocrinology: Endocrinology of Vasculature. Totawa, NJ: Humana Press, Inc; 1996: 255-267.
16. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
17. Nikkari ST, Rantala I, Pystynen P, Nikkari T. Characterization of the phenotype of smooth muscle cells in human fetal aorta on the basis of ultrastructure, immunofluorescence, and the composition of cytoskeletal and cytocontractile proteins. Atherosclerosis. 1988;74:33-40.
18. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Atherosclerosis. 1990;10:966-990.
19. Owens GK, Geisterfer AA, Yang YW, Komoriya A. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 1988; 107:771-780.
20. Duda T, Sharma RK. Regulation of guanylate cyclase activity by atrial natriuretic factor and PKC. Mol Cell Biochem. 1990;93: 179-184.
21. Potter LR, Garbers DL. Protein kinase C-dependent desensitization of the atrial natriuretic peptide receptor is mediated by dephosphorylation. J Biol Chem. 1994;269:14636-14642.
22. Pandey KN. Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor receptor in cultured vascular smooth muscle cells: ligand-dependent receptor down-regulation. Biochem J. 1992;288:55-61.
23. MacGregor G. In: Chung DC, Chassy BM, Saunders JA, Sowers AE, eds. Optimization of Electroporation Using Receptor Genes. San Diego, Calif: Academic Press; 1992:465-470.
24. Tseng C-P, Kim Y-J, Kumar R, Verma AK. Involvement of protein kinase C in the transcriptional regulation of 12-O-tetradecanoylphorbol 13-acetate-inducible genes modulated by AP-1 and non-AP-1 transacting factors. Carcinogenesis. 1994;15:707-711.
25. Keilback A, Ruth A, Hoffman F. Detection of cGMP-dependent protein kinase isoenzymes by specific antibodies. Eur J Biochem. 1992;208:467-473.
26. 4. Nature. 1970;277:680-685.
27. Towbin H, Staehlin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4354.
28. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem. 1989;264:1146-1155.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
30. Khurana ML, Pandey KN. Receptor-mediated stimulatory effect of atrial natriuretic factor, brain natriuretic peptide and C-type natriuretic peptide on stimulation of testosterone production in purified mouse Leydig cells: activation of cholesterol side-chain cleavage enzyme. Endocrinology. 1993;133:2141-2149.
31. von Geldern TW, Budzik GP, Dillon TP, Holleman WH, Holst MA, Kiso Y, Novosad EI, Opgenorth TJ, Rockway TW, Thomas AM, Yeh S. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations. Mol Pharmacol. 1990;38:771-778.
32. Norling LL, von Geldern TW, Chevalier RL. Maturation of A-71915-dependent inhibition of atrial natriuretic peptide-stimulated cyclic GMP production in isolated rat glomeruli. Biol Neonate. 1994;55:294-301.
33. Dzau VJ. The role of mechanical and hormonal factors in growth regulation of vascular smooth muscle cells and cardiac myocytes. Curr Opin Nephrol Hypertens. 1993;2:27-32.
34. Lincoln TM, Comwell TL. Intracellular cyclic GMP receptor proteins. FASEB J. 1993;7:328-338.
35. Tamm C, Lang U, Vallotton MB. Atrial natriuretic factor inhibits angiotensin II and phorbol ester-induced activation of protein kinase C in vascular smooth muscle cells. Adv Atrial Pept Res. 1988; 2:79-83.
36. Lang U, Vallotton MB. Effects of angiotensin II and phorbol ester on protein kinase C activity and on prostacyclin production in cultured rat aortic smooth muscle cells. Biochem J. 1989;259:477-484.
37. Rogers J, Hughes RG, Mathes EK. cGMP inhibits protein kinase C-mediated secretion in rat pancreatic acini. J Biol Chem. 1988; 263:3713-3719.
38. Sauro MD, Fitzpatrick DF. Atrial natriuretic peptides inhibit protein kinase C activation in rat aortic smooth muscle. Pept Res. 1990; 3:138-141.
39. Pandey KN. Atrial natriuretic factor inhibits the phosphorylation of protein kinase C in plasma membrane preparations of cultured Leydig tumor cells. J Androl. 1994;15:100-109.
40. Pandey KN. Atrial natriuretic factor inhibits autophosphorylation of protein kinase C and a 240 kDa protein in plasma membranes of bovine adrenal glomerulosa cells: involvement of cGMP-dependent and -independent signal transduction mechanisms. Mol Cell Biochem. 1994;141:103-111.
41. Cornwell TL, Soff GA, Traynor AE, Lincoln TM. Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells. J Vasc Res. 1994;31:330-337.
42. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol. 1994;267:C1405-C1413.
43. Cao L, Wu J, Gardner DG. Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor. J Biol Chem. 1995;270:24891-24897.
44. Bendhack LM, Sharma RV, Bhalla RC. Contractile response of spontaneously hypertensive rat caudal artery to phorbol esters. Hypertension. 1988;11:1112-1116.
45. Bilder GE, Kasiewski CJ, Perrone MH. Phorbol-12,13-dibutyrate-induced vasoconstriction in vitro: characterization of responses in genetic hypertension. J Pharmacol Exp Ther. 1990;252:526-530.
46. Turla MB, Park SM, Webb RC. Vascular responsiveness to phorbol esters in coarctation-hypertensive rats. J Hypertens. 1990;8:191-196.
47. Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M, Hoh E, Takaku F, Yazaki Y. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. J Biol Chem. 1991;266:1265-1268.
48. Louis JC, Magal E, Yavin E. Protein kinase C alterations in the fetal rat brain after global ischemia. J Biol Chem. 1988;263:19282-19285.
49. Kariya I, Kawahara Y, Tsuda T. Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis. 1987;63:251-255.
50. Matsumoto H, Sasaki Y. Staurosporine, a protein kinase C inhibitor, interferes with proliferation of arterial smooth muscle cells. Biochem Biophys Res Commun. 1989;158:105-109.
51. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;258:607-614.
52. 2+ influx and protein kinase C activation in sustained cellular responses. Endocr Rev. 1995;16:649-681.
53. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction. Biochem J. 1993;291:329-343.
54. Dekker LV, Parker PJ. Protein kinase C: a question of specificity. Trends Biochem Sci. 1994;19:73-77.
55. Berridge MJ, Irvine RF. Inositol phosphates and cell signaling. Nature. 1989;341:197-205.
56. Exton JH. Signaling through phosphatidylcholine breakdown. J Biol Chem. 1990;265:1-4.
57. Zwiller J, Revel MO, Malviya AN. Protein kinase C catalyses phosphorylalion of guanylate cyclase in vitro. J Biol Chem. 1985; 260:1350-1353.
58. Sugiura M, Inagami T, Hare GMT, Johns JA. Endothelin action: inhibition by protein kinase C inhibitor and involvement of phosphoinositols. Biochem Biophys Res Commun. 1989;158:170-176.
59. Kondo T, Konishi F, Inui H, Inagami T. Diacylglycerol formation from phosphatidylcholine in angiotensin II stimulated vascular smooth muscle cells. Biochem Biophys Res Commun. 1992;179: 1070-1076.
60. Khurana ML, Pandey KN. Atrial natriuretic peptide inhibits the phosphoinositide hydrolysis in murine Leydig tumor cells. Mol Cell Biochem. 1996;158:97-105.